CR1 and Alzheimer disease: Moreover, genome-wide association studies have also identified several common genetic variants that modestly increase AD risk, which are related to immune response and inflammation—such as CR1 and TREM2—suggesting that immune dysfunction and neuroinflammation play roles in AD progression.